CD4 and neoplasm: Analyses of 7 GCT specimens showed that 4.0% of total tumor single cells suspensions were CD8+ T cells, 3.3% were CD4+ T cells and 0.72% were CD4+CD25+FOXP3+ Tregs (Figure 1E).